Local presence of cytomegalovirus and candida species vs oral lesions in liver and kidney transplant recipients

Annals of Transplantation

Volumn 13, Issue 4, 2008, Pages 28-33

  Olczak Kowalczyk, Dorota ^a   Pawłowska, Joanna ^a   Cukrowska, Bozena ^a   Kluge, Przemysław ^a   Witkowska Vogtt, Ewa ^a   Dzierzanowska Fangrat, Katarzyna ^a   Wrześniewska, Danuta ^a   Śmirska, Ewa ^a   Grenda, Ryszard ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Cytomegalovirus bull; Immunosuppression bull; Oral mucosal ulceration bull; Organ transplantation bull; Peridontitis lesions

Indexed keywords

CYCLOSPORIN; CYTOMEGALOVIRUS ANTIGEN PP65; IMMUNOGLOBULIN M ANTIBODY; RAPAMYCIN; STEROID; TACROLIMUS; VIRUS DNA; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ANTIGENICITY; APHTHOUS STOMATITIS; ARTICLE; BLOOD ANALYSIS; CANDIDA; CHEILITIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DENTAL CARE; DRUG BLOOD LEVEL; GINGIVITIS; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MOUTH CAVITY; MOUTH LESION; MOUTH MUCOSA; MOUTH ULCER; MYCOLOGY; ORAL BIOPSY; POSTOPERATIVE PERIOD; THRUSH; CANDIDA ALBICANS; FOLLOW UP; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; STOMATITIS; VIROLOGY;

ADOLESCENT; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MOUTH MUCOSA; ORAL ULCER; STOMATITIS;

EID: 65849427434     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Abu-Nader R, Patel R: Current management strategies for the treatment and prevention of cytomegalovirus infection in solid organ transplant recipients. BioDrugs, 2000; 13: 159-75
2. Kuypers DRJ, Maes BD, Coosemans W et al: Roleof immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients. Transplant Proc, 2002; 34: 1164-70
3. Prokurat S, Drabik E, Grenda R et al: Ganciclovir in CMV-prophylaxis in high-risk pediatric renal transplant recipients. Transplant Proc, 1993; 25: 2577-78
4. Prokurat S, Grenda R, Ochalska M: DHPG-prophylaxis effect on incidence and severity of CMV infection in pediatric renal graft recipients treated with ATG\OKT3. Pediatric Nephrology, 1996; 10: C55
5. Prokurat S, Grenda R, Augustynowicz E et al: Does cymevene-based CMV prophylaxis introduced during rescue therapy of refractory rejection infl uence long-term renal graft survival. Pediatric Transplant,1998; 2: 120-21
6. Snydman DR: Epidemiology of infections after solid-organ transplantation. CID, 2001; 33(Suppl.1): 5-8
7. Patel R, Paya CV: Infections in solid-organ transplant recipients. Clin Microbiol Rev, 1997; 10: 86-124
8. Rowshani AT, Bemelman FJ, Leeuwen EMM et al:Clinical and immunologic aspect of cytomegalovirus in infection solid organ transplant recipients. Transplantation, 2005; 79: 381-86
9. Brennan DC: Cytomegalovirus in renal transplantation. J Am Soc Nephrol, 2001; 12: 848-55
10. Jenkins FJ, Rowe DT, Rinaldo ChR: Herpes virusinfections in organ transplant Recipients. Clin Diagn Lab Immunol, 2003; 10: 1-7
11. Singh N: Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies. J Clin Virol, 2006; 35: 474-77
12. Humar A: Reactivation of viruses in solid organ transplant patients receiving cytomegalovirus prophylaxis. Transplantation, 2006; 82(Suppl.2): 9-14
13. Strippoli GF, Hodson EM, Jones C, Craig JC: Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients. Transplantation, 2006; 81: 139-45
14. Doumas S, Vladikas A, Papagianni M, Kolokotronis A: Human cytomegalovirus-associated oral and maxillo-facial disease. Clin Microbiol Infect, 2007; 13: 557-59
15. Epstein JB, Sherlock CH, Walber RA: Oral manifestations of cytomegalovirus infection. Oral Surg Oral Med Oral Pathol, 1993; 75: 443-51
16. Saygun I, Kubar A, Özdemir A, Slots J: Periodontitis lesions are a source of salivary cytomegalovirus and Espein-Barr virus. J Periodont Res, 2005; 40: 187-91
17. Saygun I, Yapar M, Özdemir A et al: Human cytomegalovirus and Epstein-Barr virus type 1 in periodontal abscesses. Oral Microbiol Immunol, 2004; 19: 83-87
18. Sun A, Chang JG, Kao CL et al: Human cytomegalovirus as a potential etiologic agent in recurrent aphtous ulcers and Behcet's disease. J Oral Pathol Med, 1996; 25: 212-18
19. Leimola-Virtanen R, Happonen RP, Syrjanen S: Cytomegalovirus (CMV) and Heliobacter pylori (HP) found in oral mucosal ulcers. J Oral Patrol Med, 1995; 24: 14-17
20. Syrjanen S, Leimola-Virtanen R, Schmidt-Westhausen A, Reichart PA: Oral ulcers in AIDS patients frequently associated with cytomegalovirus (CMV) and Epstein-Bar virus (EBV) infections. J Oral Patrol Med, 1999; 28: 204-9
21. Firth NA, Rich AM, Reade PC: Oral mucosal ulceration due to cytomegalovirus infection. Case report and brief review. Aust Dent J, 1994; 39: 273-75
22. Dodd CL, Winkler JR, Heinic GS et al: Cytomegalovirus infection presenting as acute periodontal infection in a patient infected with the human immunodefi ciency virus. J Clin Periodontol, 1993; 20: 282-85
23. Jurge S, Kuffer R, Scully C, Porter SR: Recurrent aphtous stomatitis. Oral Disease, 2006; 12: 1-21
24. Ghodrattnama F, Riggio MP, Wray D: Search for human herpesvirus 6, human cytomegalovirus and varicella zoster virus DNA in recurrent apthous stomatitis tissue. J Oral Pathol Med, 1997; 26: 192-97
25. Olczak-Kowalczyk D, Pawlowska J, Smirska E, Grenda R: Zmiany w jamie ustnej w przebiegu zakażenia wirusem cytomegalii (CMV) u pacjentów po transplantacji narzadow - doświadczenia własne. Czas Stomat, 2004; 57: 695-99
26. Olczak-Kowalczyk D, Pawłowska J: Zmiany w Jamie ustnej w przebiegu zakażenia wirusem CMV u 16-letniego chłopca po transplantacji watroby. Standardy Medyczne, 2004; 11: 1224-26
27. Olczak-Kowalczyk D, Śmirska E, Kluge P, CukrowskaB: Changes in oral mucosa during CMV infection in patient after renal transplantation. Annals of Diagnostic Paediatric Pathology, 2007; 11: 107-9
28. Grenda R, Watson A, Vondrak K et al: Tacrolimus triple therapy with and without monoclonal antibody administration: a multicenter, randomized study in pediatric kidney transplantation. Am J Transplant, 2006; 6: 1666-72
29. Khoury JA, Storch GA, Bohl DL: Prophylactic versus preemptive oral valganciclovir for the management if CMV infection in adult renal transplant recipients. Am J Transplant, 2006; 6: 2134-43
30. Rubik J, Kozłowski K, Grenda R, Prokurat S: Evaluation of pharmacokinetics and safety of valganciclovir oral suspension treatment in pediatric kidney graft recipients. Przegl Lek, 2006; 63: 184-86